| Dr Lisa Vanderbilt Knopf, MD | |
|
80 Seymour Street, Hartford Hospital Neurology Dept, Hartford, CT 06102-5037 | |
| (860) 972-9047 | |
| Not Available |
| Full Name | Dr Lisa Vanderbilt Knopf |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 13 Years |
| Location | 80 Seymour Street, Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073806345 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hartford Hospital | Hartford, CT | Hospital |
| The Hospital Of Central Connecticut | New britain, CT | Hospital |
| William W Backus Hospital | Norwich, CT | Hospital |
| Midstate Medical Center | Meriden, CT | Hospital |
| Charlotte Hungerford Hospital | Torrington, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
News Archive
Cambridge Research Biochemicals® (CRB), a longstanding British company specialising in the synthesis of custom peptides and the generation of bespoke antibodies for pharmaceutical and medical research, today announced the release of its new DISCOVERY® Antibodies catalogue. This ties in with the three year anniversary of CRB's expansion and relocation which took place in January 2014 and secures the company's position as a key player in the life science industry as we enter 2017.
Rare genetic diseases, long overlooked because they affect relatively few people, are getting new attention. Scientists at Washington University School of Medicine in St. Louis are reaching out to patient advocacy groups and offering to decode the DNA of 99 patients with rare diseases to help find the genetic alterations responsible for their illnesses.
A Buckinghamshire town is considering banning smoking from its streets. Stony Stratford town councilor Paul Bartlett is spearheading a campaign which would forbid residents from smoking on the streets.
The number of people killed or seriously injured at sites where safety cameras are in use has fallen by 40%, UK Transport Secretary Alistair Darling has announced. This equates to over 100 fewer deaths a year.
Researchers from Boston University School of Medicine have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease (AD) in the brain and improves learning and memory in two experimental AD models.
› Verified 5 days ago
| Entity Name | Hartford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407806391 PECOS PAC ID: 2567366016 Enrollment ID: O20031125000700 |
News Archive
Cambridge Research Biochemicals® (CRB), a longstanding British company specialising in the synthesis of custom peptides and the generation of bespoke antibodies for pharmaceutical and medical research, today announced the release of its new DISCOVERY® Antibodies catalogue. This ties in with the three year anniversary of CRB's expansion and relocation which took place in January 2014 and secures the company's position as a key player in the life science industry as we enter 2017.
Rare genetic diseases, long overlooked because they affect relatively few people, are getting new attention. Scientists at Washington University School of Medicine in St. Louis are reaching out to patient advocacy groups and offering to decode the DNA of 99 patients with rare diseases to help find the genetic alterations responsible for their illnesses.
A Buckinghamshire town is considering banning smoking from its streets. Stony Stratford town councilor Paul Bartlett is spearheading a campaign which would forbid residents from smoking on the streets.
The number of people killed or seriously injured at sites where safety cameras are in use has fallen by 40%, UK Transport Secretary Alistair Darling has announced. This equates to over 100 fewer deaths a year.
Researchers from Boston University School of Medicine have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease (AD) in the brain and improves learning and memory in two experimental AD models.
› Verified 5 days ago
| Entity Name | Hartford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770696643 PECOS PAC ID: 2567366016 Enrollment ID: O20031125000752 |
News Archive
Cambridge Research Biochemicals® (CRB), a longstanding British company specialising in the synthesis of custom peptides and the generation of bespoke antibodies for pharmaceutical and medical research, today announced the release of its new DISCOVERY® Antibodies catalogue. This ties in with the three year anniversary of CRB's expansion and relocation which took place in January 2014 and secures the company's position as a key player in the life science industry as we enter 2017.
Rare genetic diseases, long overlooked because they affect relatively few people, are getting new attention. Scientists at Washington University School of Medicine in St. Louis are reaching out to patient advocacy groups and offering to decode the DNA of 99 patients with rare diseases to help find the genetic alterations responsible for their illnesses.
A Buckinghamshire town is considering banning smoking from its streets. Stony Stratford town councilor Paul Bartlett is spearheading a campaign which would forbid residents from smoking on the streets.
The number of people killed or seriously injured at sites where safety cameras are in use has fallen by 40%, UK Transport Secretary Alistair Darling has announced. This equates to over 100 fewer deaths a year.
Researchers from Boston University School of Medicine have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease (AD) in the brain and improves learning and memory in two experimental AD models.
› Verified 5 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
Cambridge Research Biochemicals® (CRB), a longstanding British company specialising in the synthesis of custom peptides and the generation of bespoke antibodies for pharmaceutical and medical research, today announced the release of its new DISCOVERY® Antibodies catalogue. This ties in with the three year anniversary of CRB's expansion and relocation which took place in January 2014 and secures the company's position as a key player in the life science industry as we enter 2017.
Rare genetic diseases, long overlooked because they affect relatively few people, are getting new attention. Scientists at Washington University School of Medicine in St. Louis are reaching out to patient advocacy groups and offering to decode the DNA of 99 patients with rare diseases to help find the genetic alterations responsible for their illnesses.
A Buckinghamshire town is considering banning smoking from its streets. Stony Stratford town councilor Paul Bartlett is spearheading a campaign which would forbid residents from smoking on the streets.
The number of people killed or seriously injured at sites where safety cameras are in use has fallen by 40%, UK Transport Secretary Alistair Darling has announced. This equates to over 100 fewer deaths a year.
Researchers from Boston University School of Medicine have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease (AD) in the brain and improves learning and memory in two experimental AD models.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lisa Vanderbilt Knopf, MD 80 Seymour Street, Hartford Hospital Neurology Dept, Hartford, CT 06102-5037 Ph: (860) 972-3621 | Dr Lisa Vanderbilt Knopf, MD 80 Seymour Street, Hartford Hospital Neurology Dept, Hartford, CT 06102-5037 Ph: (860) 972-9047 |
News Archive
Cambridge Research Biochemicals® (CRB), a longstanding British company specialising in the synthesis of custom peptides and the generation of bespoke antibodies for pharmaceutical and medical research, today announced the release of its new DISCOVERY® Antibodies catalogue. This ties in with the three year anniversary of CRB's expansion and relocation which took place in January 2014 and secures the company's position as a key player in the life science industry as we enter 2017.
Rare genetic diseases, long overlooked because they affect relatively few people, are getting new attention. Scientists at Washington University School of Medicine in St. Louis are reaching out to patient advocacy groups and offering to decode the DNA of 99 patients with rare diseases to help find the genetic alterations responsible for their illnesses.
A Buckinghamshire town is considering banning smoking from its streets. Stony Stratford town councilor Paul Bartlett is spearheading a campaign which would forbid residents from smoking on the streets.
The number of people killed or seriously injured at sites where safety cameras are in use has fallen by 40%, UK Transport Secretary Alistair Darling has announced. This equates to over 100 fewer deaths a year.
Researchers from Boston University School of Medicine have found that the diabetic drug, pramlintide, reduces amyloid-beta peptides, a major component of Alzheimer's disease (AD) in the brain and improves learning and memory in two experimental AD models.
› Verified 5 days ago
Bentley Andrew Strockbine, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 200 Retreat Ave, Hartford, CT 06106 Phone: 860-545-7410 | |
Dr. Alfred Herzog, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 80 Seymour Street, Hartford Hospital, Hartford, CT 06102 Phone: 860-545-3501 | |
J Daane Logsdon, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 200 Retreat Ave, Hartford Hospital Psychiatry Dept, Hartford, CT 06106 Phone: 860-545-7250 | |
Crystal Diane Salcido, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 200 Retreat Avenue, Hartford Hospital Psychiatry Dept, Hartford, CT 06106 Phone: 860-545-7064 | |
Robert F Swords, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 675 Tower Ave, Suite 301, Hartford, CT 06112 Phone: 860-714-2750 Fax: 860-714-8591 | |
Samira Savill Solomon, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 200 Retreat Ave, Hartford Hospital Psychiatry Dept., Hartford, CT 06106 Phone: 860-545-7330 | |
Dr. Ainsley E Backman, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 200 Retreat Ave, Hartford, CT 06106 Phone: 860-545-7062 |